143 related articles for article (PubMed ID: 4002201)
1. Fibrinogen Baltimore IV: congenital dysfibrinogenemia with delayed fibrin monomer polymerization.
Ebert RF; Bell WR
Thromb Res; 1985 Apr; 38(2):121-8. PubMed ID: 4002201
[TBL] [Abstract][Full Text] [Related]
2. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
Brown CH; Crowe MF
J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
[TBL] [Abstract][Full Text] [Related]
3. A hereditary dysfibrinogenemia: fibrinogen Awaji.
Matsuo T; Okuno S; Mukaida T; Ueshima S; Okada K; Matsuo O
Haemostasis; 1987; 17(1-2):89-97. PubMed ID: 3596361
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".
Lounes KC; Soria C; Mirshahi SS; Desvignes P; Mirshahi M; Bertrand O; Bonnet P; Koopman J; Soria J
Blood; 2000 Nov; 96(10):3473-9. PubMed ID: 11071644
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Baltimore IV: congenital dysfibrinogenemia with a gamma 275 (Arg----Cys) substitution.
Schmelzer CH; Ebert RF; Bell WR
Thromb Res; 1989 Oct; 56(2):307-16. PubMed ID: 2617471
[TBL] [Abstract][Full Text] [Related]
6. An abnormal inherited fibrinogen (fibrinogen Genova) with delayed fibrin aggregation.
Hassan HJ; Orlando M; Tonini GP; Casalbore P; Sarti A; Boeri E; Giacchino R; Tentori L; Mori PG
Scand J Haematol; 1982 Oct; 29(4):287-94. PubMed ID: 7178834
[TBL] [Abstract][Full Text] [Related]
7. [Fibrinogen Quebec I and Quebec II: two new families of dysfibrinogenemia (author's transl)].
Jobin F; Vu L; Delage JM
Acta Haematol; 1978; 59(2):119-27. PubMed ID: 415477
[TBL] [Abstract][Full Text] [Related]
8. Fibrin monomers derived from thrombogenic dysfibrinogenemia, Naples-type variant (BβAla68Thr), showed almost entirely normal polymerization.
Kamijo T; Nagata K; Taira C; Higuchi Y; Arai S; Okumura N
Thromb Res; 2018 Dec; 172():1-3. PubMed ID: 30321757
[No Abstract] [Full Text] [Related]
9. Fibrinogen Oviedo I. A new Spanish dysfibrinogenaemia.
Fernández FJ; Rodríguez Pinto C; Páramo J; Cuesta B; Collado M; Rocha E
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):571-5. PubMed ID: 2133236
[TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
Rodeghiero F; Castaman GC; Dal Belin Peruffo A; Dini E; Galletti A; Barone E; Gastaldi G
Thromb Haemost; 1987 Jun; 57(3):252-8. PubMed ID: 2958952
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release.
Yan J; Luo M; Cheng P; Liao L; Deng X; Deng D; Lin F
Int J Hematol; 2017 Apr; 105(4):506-514. PubMed ID: 27933517
[TBL] [Abstract][Full Text] [Related]
12. Acquired Dysfibrinogenemia Caused by Autoantibody Inhibiting Fibrin Polymerization in a Patient with MELAS Syndrome and Bleeding Tendency.
Lee N; Kim JE; Yoo HJ; Gu J; Kim H; Chung J; Koh Y; Kim HK
Ann Clin Lab Sci; 2016 Dec; 46(6):696-700. PubMed ID: 27993886
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen Guarenas I: partial characterization of a new dysfibrinogenemia with an altered rate of fibrinopeptide release and an impaired polymerization.
Lundberg UG; Rodriguez S; Marchi R; Ruiz-Saez A; Arocha-Piñango CL
Thromb Res; 1995 Apr; 78(2):95-106. PubMed ID: 7482436
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Troyes--fibrinogen Metz. Two new cases of congenital dysfibrinogenemia.
Soria J; Soria C; Samama M; Poirot E; Kling C
Thromb Diath Haemorrh; 1972 Jul; 27(3):619-33. PubMed ID: 4662617
[No Abstract] [Full Text] [Related]
15. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
[TBL] [Abstract][Full Text] [Related]
16. Dysfibrinogenemia: a case with thrombosis (fibrinogen Richfield) and an overview of the clinical and laboratory spectrum.
Schorer AE; Singh J; Basara ML
Am J Hematol; 1995 Nov; 50(3):200-8. PubMed ID: 7485081
[TBL] [Abstract][Full Text] [Related]
17. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
Lane DA; Cuddigan B; VanRoss M; Kakkar VV
Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460
[TBL] [Abstract][Full Text] [Related]
18. ["Fibrinogen Kawaguchi": a hereditary dysfibrinogenemia characterized by defective release of fibrinopeptide A associated with altered polymerization of fibrin monomers].
Saeki E; Matsuda M; Ichinose A; Samejima Y; Kasamatsu A; Ara R; Mitsuno K; Kihara T; Hara Y
Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1229-35. PubMed ID: 4072586
[No Abstract] [Full Text] [Related]
19. Dysfibrinogenemia in childhood: two cases of congenital dysfibrinogens.
Kotlín R; Blažek B; Suttnar J; Malý M; Kvasnička J; Dyr JE
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):640-8. PubMed ID: 20829681
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
